JPMorgan Chase & Co. Cuts U.S. Physical Therapy (NYSE:USPH) Price Target to $110.00

U.S. Physical Therapy (NYSE:USPH) had its price target lowered by JPMorgan Chase & Co. from $120.00 to $110.00 in a research report report published on Wednesday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

A number of other research firms have also commented on USPH. StockNews.com lowered U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Friday, February 28th. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Barrington Research decreased their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. Finally, William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $109.00.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH opened at $72.52 on Wednesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The firm has a market cap of $1.10 billion, a price-to-earnings ratio of 77.14, a P/E/G ratio of 3.54 and a beta of 1.51. The stock’s fifty day moving average price is $84.85 and its two-hundred day moving average price is $86.99. U.S. Physical Therapy has a one year low of $72.27 and a one year high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. On average, equities analysts forecast that U.S. Physical Therapy will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be paid a $0.45 dividend. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.48%. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 97.83%.

Insider Activity at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This represents a 19.44 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Several hedge funds have recently added to or reduced their stakes in the business. CBIZ Investment Advisory Services LLC raised its stake in shares of U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after acquiring an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in U.S. Physical Therapy in the fourth quarter valued at $39,000. Venturi Wealth Management LLC raised its position in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after purchasing an additional 704 shares during the last quarter. KBC Group NV lifted its holdings in U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after buying an additional 315 shares during the period. Finally, Lazard Asset Management LLC bought a new stake in shares of U.S. Physical Therapy in the 4th quarter valued at about $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.